{"id":"556609-8421","orgnr":"556609-8421","name":"Biofol AB","name_registered_on":"2001-06-28","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2001-04-10","business_description":"Bolaget skall bedriva forskning och utveckling av medicintekniska produkter, äga och förvalta fast egendom och lös egendom såsom aktier, andelar och värdepapper samt konsultverksamhet inom medicintekniska området och därmed förenlig verksamhet.","industries":[{"code":"71122","name":"Teknisk konsultverksamhet inom industriteknik"}],"postal_address":{"city":"BRASTAD","country":"SE","municipality":{"code":"1484","name":"Lysekil"},"county":{"code":"14","name":"Västra Götalands län"}},"registered_office":{"municipality":{"code":"1484","name":"Lysekil"},"county":{"code":"14","name":"Västra Götalands län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-07-01","to":"2025-06-30","framework":"K2","signed_on":"2025-12-18","documents":{"annual_report":"/v1/documents/d4db8380-47bc-4844-bc99-c3d4088a080d.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/03_1.zip"}},{"from":"2021-07-01","to":"2022-06-30","framework":"K2","signed_on":"2022-12-01","documents":{"annual_report":"/v1/documents/880ecbbb-7b2b-4b76-836b-cf9349b2e443.xhtml","audit_report":"/v1/documents/ff15503a-f12a-4b70-a0a0-6ddf5a045ded.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/03_1.zip"}},{"from":"2020-07-01","to":"2021-06-30","framework":"K2","signed_on":"2021-12-13","documents":{"annual_report":"/v1/documents/28dcbbd5-090d-46cc-866a-0c1ad4df606d.xhtml","audit_report":"/v1/documents/574cbea1-6e9f-4299-9e26-745421e7f52e.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/02_1.zip"}},{"from":"2019-07-01","to":"2020-06-30","framework":"K2","signed_on":"2020-11-25","documents":{"annual_report":"/v1/documents/6589d0b9-158e-4a85-8847-0be739b15bb8.xhtml","audit_report":"/v1/documents/cb861350-82d4-47b9-a5b8-02d35532ef3d.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/04_1.zip"}}],"latest_financials":{"from":"2024-07-01","to":"2025-06-30","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-982476,"profit_after_financial_items":-42942,"net_profit":-42942,"total_assets":5521432,"current_assets":215747,"equity":1037874,"share_capital":100000,"unrestricted_equity":917874,"current_liabilities":4483558,"tax_liabilities":609,"cash":37579,"staff_costs":202380,"employees":1,"equity_ratio":0.1879,"net_sales_growth":-1,"source":{"annual_report":"2025-06-30","document":"/v1/documents/d4db8380-47bc-4844-bc99-c3d4088a080d.xhtml"},"anchors":{"cash":{"text":"37 579","prefix":"bank"},"current_assets":{"text":"215 747"},"current_liabilities":{"text":"4 483 558"},"employees":{"text":"1,00","prefix":"varit"},"equity":{"text":"1 037 874","prefix":"kapital"},"equity_ratio":{"text":"18,79"},"net_sales":{"text":"0"},"operating_profit":{"text":"982 476","suffix":"-247"},"profit_after_financial_items":{"text":"42 942"},"share_capital":{"text":"100 000","prefix":"utgång"},"staff_costs":{"text":"202 380"},"tax_liabilities":{"text":"609"},"total_assets":{"text":"5 521 432","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"917 874","prefix":"942"}}},"officers":{"annual_report":"2025-06-30","signed_on":"2025-12-18","signatories":[{"name":"B*****"},{"name":"E*****"},{"name":"L*****"}]},"group":{"parents":[{"id":"556739-2955","name":"Biofol Holding AB","list":"complete"}],"source":{"by":"parent","annual_report":"2025-06-30"},"capital_share":1}}